Watching Akamai Technologies; Hearing Co. Received Takeover Approach from Private Equity Firm – Sources

– Bloomberg 

– Bloomberg 

Total
0
Shares
Related Posts
Read More

Seres Therapeutics and Nestlé Health Science Present Results from ECOSPOR IV Phase 3 Study of VOWST, a Microbiota-Based Oral Therapeutic for Prevention of Recurrence of C. Difficile Infection, at the Digestive Disease Week (DDW) Annual Meeting

Seres Therapeutics, Inc. (NASDAQ:MCRB), and Nestlé Health Science today announced the presentation of data from the Phase 3 open-label ECOSPOR IV study evaluating VOWST (fecal microbiota spores,

MCRB